Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Decline in ACEI/ARB Prescribing as Heart Failure Core Metrics Improve During Computer-Based Clinical Decision Support.

Caraballo PJ, Naessens JM, Klarich MJ, Leutink DJ, Peterson JA, Wagie AE, Manning DM, Qian Q.

Am J Med Qual. 2014 Jul-Aug;29(4):300-7. doi: 10.1177/1062860613509265. Epub 2013 Nov 18.

PMID:
24249835
2.

Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.

Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A.

Am J Med. 2016 Oct;129(10):1067-73. doi: 10.1016/j.amjmed.2016.05.008. Epub 2016 Jun 2.

3.

ACEi/ARB for systolic heart failure: closing the quality gap with a sustainable intervention at an academic medical center.

Qian Q, Manning DM, Ou N, Klarich MJ, Leutink DJ, Loth AR, Lopez-Jimenez F.

J Hosp Med. 2011 Mar;6(3):156-60. doi: 10.1002/jhm.803.

PMID:
20652962
4.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
5.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

6.

General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.

Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T.

Clin Res Cardiol. 2016 May;105(5):441-50. doi: 10.1007/s00392-015-0939-8. Epub 2015 Nov 9.

PMID:
26552905
7.

Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.

Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.

Eur J Heart Fail. 2015 Apr;17(4):442-52. doi: 10.1002/ejhf.252. Epub 2015 Mar 2.

8.

Readmissions and the quality of care in patients hospitalized with heart failure.

Luthi JC, Lund MJ, Sampietro-Colom L, Kleinbaum DG, Ballard DJ, McClellan WM.

Int J Qual Health Care. 2003 Oct;15(5):413-21.

PMID:
14527985
9.

Designing a comprehensive strategy to improve one core measure: discharge of patients with myocardial infarction or heart failure on ACE inhibitors/ARBs.

Santana C, Shaines M, Choi P, Bhalla R.

Am J Med Qual. 2012 Sep-Oct;27(5):398-405. doi: 10.1177/1062860611431762. Epub 2012 Feb 16.

PMID:
22345132
10.

Analysis Treatment Guideline versus Clinical Practice Protocol in Patients Hospitalized due to Heart Failure.

Corrêa Ada G, Makdisse M, Katz M, Santana TC, Yokota PK, Galvão Tde F, Bacal F.

Arq Bras Cardiol. 2016 Mar;106(3):210-7. doi: 10.5935/abc.20160018. Epub 2016 Jan 26. English, Portuguese.

11.

Association between process quality measures for heart failure and mortality among US veterans.

Wu WC, Jiang L, Friedmann PD, Trivedi A.

Am Heart J. 2014 Nov;168(5):713-20. doi: 10.1016/j.ahj.2014.06.024. Epub 2014 Jul 11.

12.

Effectiveness of a clinical-decision-support system in improving compliance with cardiac-care quality measures and supporting resident training.

Riggio JM, Sorokin R, Moxey ED, Mather P, Gould S, Kane GC.

Acad Med. 2009 Dec;84(12):1719-26. doi: 10.1097/ACM.0b013e3181bf51d6.

PMID:
19940579
13.

Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland.

Wan Md Adnan WA, Zaharan NL, Bennett K, Wall CA.

Br J Clin Pharmacol. 2011 Mar;71(3):458-66. doi: 10.1111/j.1365-2125.2010.03835.x.

14.

Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.

Driscoll A, Currey J, Tonkin A, Krum H.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD009889. doi: 10.1002/14651858.CD009889.pub2. Review.

PMID:
26689943
15.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.

Zhang L, Zeng X, Fu P, Wu HM.

Cochrane Database Syst Rev. 2014 Jun 23;(6):CD009120. doi: 10.1002/14651858.CD009120.pub2. Review.

PMID:
24953826
16.

Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.

Wawruch M, Slezakova V, Murin J, Luha J, Bozik M, Leitmann T, Kuzelova M, Shah R.

Aging Clin Exp Res. 2014 Jun;26(3):307-14. doi: 10.1007/s40520-014-0231-1. Epub 2014 Apr 30.

PMID:
24781831
17.

Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.

Chen JY, Kang N, Juarez DT, Yermilov I, Braithwaite RS, Hodges KA, Legorreta A, Chung RS.

J Healthc Qual. 2011 Jul-Aug;33(4):29-36. doi: 10.1111/j.1945-1474.2010.00124.x. Epub 2011 Jan 18.

PMID:
21733022
18.

Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.

Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Hypertens Res. 2010 Mar;33(3):197-202. doi: 10.1038/hr.2009.199. Epub 2009 Dec 4.

PMID:
19960016
19.

Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.

Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Zhao X, Schwamm LH, Bhatt DL.

Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):227-35. doi: 10.1161/CIRCOUTCOMES.113.000422. Epub 2014 Feb 25.

20.

Supplemental Content

Support Center